Enzolytics Book Value Per Share vs. Return On Asset
| ENZC Stock | USD 0 0.0001 11.11% |
For Enzolytics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Enzolytics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Enzolytics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Enzolytics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Enzolytics over time as well as its relative position and ranking within its peers.
Enzolytics |
Enzolytics Return On Asset vs. Book Value Per Share Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Enzolytics's current stock value. Our valuation model uses many indicators to compare Enzolytics value to that of its competitors to determine the firm's financial worth. Enzolytics is rated # 4 in book value per share category among its peers. It also is rated # 4 in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Enzolytics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Enzolytics' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Enzolytics Return On Asset vs. Book Value Per Share
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Enzolytics |
| = | (0.63) X |
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Enzolytics |
| = | -7.05 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Enzolytics Return On Asset Comparison
Enzolytics is currently under evaluation in return on asset category among its peers.
Enzolytics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Enzolytics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Enzolytics will eventually generate negative long term returns. The profitability progress is the general direction of Enzolytics' change in net profit over the period of time. It can combine multiple indicators of Enzolytics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Enzolytics, Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. In addition, it has created a proprietary cell line that produces human monoclonal antibodies that target and neutralizes the HIV virus. Enzolytics operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Enzolytics Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Enzolytics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Enzolytics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Enzolytics' important profitability drivers and their relationship over time.
Use Enzolytics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Enzolytics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enzolytics will appreciate offsetting losses from the drop in the long position's value.Enzolytics Pair Trading
Enzolytics Pair Trading Analysis
The ability to find closely correlated positions to Enzolytics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Enzolytics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Enzolytics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Enzolytics to buy it.
The correlation of Enzolytics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Enzolytics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Enzolytics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Enzolytics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Enzolytics position
In addition to having Enzolytics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Single Stock ETFs Thematic Idea Now
Single Stock ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Single Stock ETFs theme has 99 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Single Stock ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Enzolytics Pink Sheet
To fully project Enzolytics' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Enzolytics at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Enzolytics' income statement, its balance sheet, and the statement of cash flows.